M. Daubert, P. Pibarot, R. Hahn
Mar 17, 2015
Citations
0
Influential Citations
0
Citations
Quality indicators
Journal
Journal of the American College of Cardiology
Abstract
Disclosures Dr. Pibarot holds the Canada Research Chair in Valvular Heart Diseases, Canadian Institutes of Health Research, Ottawa, Ontario, Canada and has received grant support from Edwards Lifesciences. Dr. Hahn has received a research grant from Philips Healthcare and consulting fees from Edwards Lifesciences. Dr. Weissman has received grant support from Boston Scientific. Dr. Lindman is supported by K23 HL116660 from the NIH, receives grant support from Roche Diagnostics, and is a member of the scientific advisory board of Roche Diagnostics. Dr. Suri is a member of the Steering Committees of the COAPT Trial (Abbott Vascular) and the PORTICO Trial (St. Jude), national PI of the PERCEVAL Trial (Sorin Medical), has patent applications with Sorin, and has received research grants from Sorin, Edwards, Abbott, and St. Jude. Dr. Douglas’ institution has received grant support from Edwards Lifesciences. Dr. Tuzcu and Dr. Leon are unpaid members of the PARTNER Trial Executive Committee. The other authors report no potential conflicts of interest. • All 2358 patients receiving TAVR in the PARTNER I Trial (cohort A, B and continued access) from May 11, 2007 through January 19, 2012 were analyzed.